Pharmacogenomic Analysis Reveals <i>CCNA2</i> as a Predictive Biomarker of Sensitivity to Polo-Like Kinase I Inhibitor in Gastric Cancer

Por Yunji Lee, Chae Eun Lee, Sejin Oh, Hakhyun Kim, Jooyoung Lee, Sang Bum Kim, Hyun Seok Kim
Publicado em 2020-05-01

A Novel Bacterium, Butyricimonas virosa, Preventing HFD-Induced Diabetes and Metabolic Disorders in Mice via GLP-1 Receptor

Por Heetae Lee, Jinho An, Jiyeon Kim, Dohyun Choi, Youngcheon Song, Chong-Kil Lee, Hyunseok Kong, Sang Bum Kim, Kyungjae Kim
Publicado em 2022-05-01

Rumen fermentation and microbial community composition influenced by live Enterococcus faecium supplementation

Por Lovelia L. Mamuad, Seon Ho Kim, Ashraf A. Biswas, Zhongtang Yu, Kwang-Keun Cho, Sang-Bum Kim, Kichoon Lee, Sang Suk Lee
Publicado em 2019-07-01

Modulation of Rat Hepatic CYP1A and 2C Activity by Honokiol and Magnolol: Differential Effects on Phenacetin and Diclofenac Pharmacokinetics In Vivo

Por Sang-Bum Kim, Kyu-Sang Kim, Heon-Min Ryu, Seong-Ho Hong, Bo-Kyoung Kim, Dae-Duk Kim, Jin Woo Park, In-Soo Yoon
Publicado em 2018-06-01

Verification of the Necessity of the Tolyl Group of PF-543 for Sphingosine Kinase 1 Inhibitory Activity

Por Su Bin Kim, Taeho Lee, Hong Seop Moon, Sung Hwan Ki, Yoon Sin Oh, Joo-Youn Lee, Sang-Bum Kim, Jeong-Eun Park, Yongseok Kwon, Sanghee Kim, Dong Jae Baek, Eun-Young Park
Publicado em 2020-05-01